These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 4155950
1. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy]. Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H. Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950 [No Abstract] [Full Text] [Related]
2. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 4. Results of a summarizing evaluation with factor analysis and multiple regression analysis]. Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H. Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1879-93. PubMed ID: 4155951 [No Abstract] [Full Text] [Related]
3. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 2. The importance of anamnestic and diagnostic characteristics for successful therapy]. Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H. Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1864-72. PubMed ID: 4615714 [No Abstract] [Full Text] [Related]
7. [Value of dilazep in the treatment of coronary insufficiency. A randomized and double-blind study on subjects with stable, exertion angina]. Romano M, De Caprio L, Scarafile P, Carlomagno A, Meccariello P, Condorelli M. Minerva Cardioangiol; 1980 Nov; 28(7-8):489-94. PubMed ID: 7005711 [No Abstract] [Full Text] [Related]
8. [Problems of combined therapy with cardiac glycosides and anti-anginal drugs (author's transl)]. Klaus W. Arzneimittelforschung; 1977 Nov; 27(3a):731-6. PubMed ID: 17417 [Abstract] [Full Text] [Related]
13. [Review of the literature and report of experiments relating to the coronaroactive drug, hexobendine]. Marmo E, Caputi AP, Cataldi S. Minerva Cardioangiol; 1972 Oct; 20(10):571-81. PubMed ID: 4562623 [No Abstract] [Full Text] [Related]
14. [Treatment of ischemic heart disease with "coronary drugs" (author's transl)]. Heinecker R. MMW Munch Med Wochenschr; 1977 Jan 07; 119(1):7-10. PubMed ID: 13298 [Abstract] [Full Text] [Related]
15. [Therapeutic possibilities of 3,4,5-trimethoxybenzoyl-epsilon-amino-caproic acid (C-3) in non-infarctual coronary pain syndrome]. De' Thomatis M. Minerva Med; 1974 Feb 17; 65(12):657-70. PubMed ID: 4150491 [No Abstract] [Full Text] [Related]
16. [Carbochromen in therapy of acute and chronic coronary insufficiency]. Votcal BE, Lozinskij LG. Arzneimittelforschung; 1970 Mar 17; 20():459-60. PubMed ID: 4989254 [No Abstract] [Full Text] [Related]
19. [Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency]. Ballerini A. Minerva Cardioangiol; 1971 May 17; 19(5):272-6. PubMed ID: 4397515 [No Abstract] [Full Text] [Related]
20. [Drug therapy of coronary insufficiency]. Hilger HH, Tauchert M. Internist (Berl); 1977 Jun 17; 18(6):315-21. PubMed ID: 18424 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]